论文部分内容阅读
目的 评价血清TSGF在肺癌诊断中的意义。方法 对 6 4例临床诊断为肺癌 ,36例肺良性病变 (BPD)患者血清TSGF的检测 ,并与 42例正常人对照。结果 肺癌组TSGF为 81.2 8± 14 .5 7u/ml,阳性率 81.2 % ,与BPD组及正常对照组有显著性差异 ,P <0 .0 1;BPD组治疗前与正常对照组有显著性差异 ,P <0 .0 1;BPD组抗炎治疗 2周后与正常对照组无显著性差异 ,P >0 .0 5。结论 TSGF作为新型的肿瘤标志物对肺癌的诊断具有广谱性、敏感性、特异性较高 ,它在肺癌的辅助诊断中有一定价值。
Objective To evaluate the significance of serum TSGF in the diagnosis of lung cancer. Methods Serum TSGF levels were measured in 64 cases of lung cancer and 36 cases of benign lung disease (BPD) and were compared with 42 normal controls. Results The TSGF of lung cancer group was 81.2 8 ± 14.57u / ml, the positive rate was 81.2%, which was significantly different from that of BPD group and normal control group (P <0.01); BPD group had significant difference compared with normal control group before treatment P <0.01; there was no significant difference between BPD group and normal control group after 2 weeks of anti-inflammatory treatment (P> 0.05). Conclusion As a new tumor marker, TSGF has broad spectrum, high sensitivity and specificity in the diagnosis of lung cancer. It has certain value in the diagnosis of lung cancer.